116 related articles for article (PubMed ID: 28728144)
1. Retinal Penetration of Intravitreally Injected Tissue Plasminogen Activator: A Rat Model Study.
Tal K; Dotan A; Nisgav Y; Dachbash M; Gal-Or O; Ehrlich R; Gaton DD; Weinberger D; Livnat T
Ophthalmic Res; 2018; 59(4):235-240. PubMed ID: 28728144
[TBL] [Abstract][Full Text] [Related]
2. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
Kamei M; Misono K; Lewis H
Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
[TBL] [Abstract][Full Text] [Related]
3. A study of retinal penetration of intravitreal tenecteplase in pigs.
Kwan AS; Vijayasekaran S; McAllister IL; Yu PK; Yu DY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2662-7. PubMed ID: 16723484
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
Coll GE; Sparrow JR; Marinovic A; Chang S
Retina; 1995; 15(4):319-26. PubMed ID: 8545578
[TBL] [Abstract][Full Text] [Related]
5. Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.
Yamamoto T; Kamei M; Kunavisarut P; Suzuki M; Tano Y
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):509-14. PubMed ID: 17960414
[TBL] [Abstract][Full Text] [Related]
6. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Hesse L; Schroeder B; Heller G; Kroll P
Retina; 2000; 20(5):500-5. PubMed ID: 11039425
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions.
McAllister IL; Vijayasekaran S; Yu DY
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4910-8. PubMed ID: 23766477
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage.
Bell JE; Shulman JP; Swan RJ; Teske MP; Bernstein PS
Ophthalmic Surg Lasers Imaging Retina; 2017 Jan; 48(1):26-32. PubMed ID: 28060391
[TBL] [Abstract][Full Text] [Related]
9. Subretinal versus intravitreal injection of recombinant tissue plasminogen activator in post-traumatic submacular haemorrhages.
Buschini E; Iannetta D; Lesnik Oberstein SY; Bijl HM; Mura M
Acta Ophthalmol; 2016 May; 94(3):307-9. PubMed ID: 26283643
[No Abstract] [Full Text] [Related]
10. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
11. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Tissue Plasminogen Activator Injection for the Treatment of Proliferative Vitreoretinopathy in a Rabbit Model.
Reitblat O; Barayev E; Gal-Or O; Tsessler M; Dotan A
Ophthalmic Res; 2023; 66(1):48-56. PubMed ID: 35772382
[TBL] [Abstract][Full Text] [Related]
13. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control.
Pulido JS; Bakri SJ; Valyi-Nagy T; Shukla D
Retina; 2007 Oct; 27(8):1071-3. PubMed ID: 18040247
[TBL] [Abstract][Full Text] [Related]
14. Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-Induced Choroidal Neovascularization in Mice.
Ozone D; Mizutani T; Nozaki M; Ohbayashi M; Hasegawa N; Kato A; Yasukawa T; Ogura Y
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5348-5354. PubMed ID: 27727399
[TBL] [Abstract][Full Text] [Related]
15. Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.
Gerometta R; Kumar S; Shah S; Alvarez L; Candia O; Danias J
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7903-9. PubMed ID: 24176900
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator.
Fujikawa M; Sawada O; Miyake T; Kakinoki M; Sawada T; Kawamura H; Sakaguchi H; Gomi F; Ohji M
Retina; 2013 Oct; 33(9):1908-14. PubMed ID: 23594720
[TBL] [Abstract][Full Text] [Related]
17. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.
Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM
Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
19. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
Handwerger BA; Blodi BA; Chandra SR; Olsen TW; Stevens TS
Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
[TBL] [Abstract][Full Text] [Related]
20. [Intravitreal injection. Drugs to treat subretinal hemorrhage].
Hesse L
Ophthalmologe; 2012 Jul; 109(7):644-7. PubMed ID: 22752625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
